Publication: COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
dc.contributor.author | Nicholas J. White | en_US |
dc.contributor.author | James A. Watson | en_US |
dc.contributor.author | Richard M. Hoglund | en_US |
dc.contributor.author | Xin Hui S. Chan | en_US |
dc.contributor.author | Phaik Yeong Cheah | en_US |
dc.contributor.author | Joel Tarning | en_US |
dc.contributor.other | Hospital for Tropical Diseases | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.contributor.other | Nuffield Department of Medicine | en_US |
dc.date.accessioned | 2020-10-05T05:45:55Z | |
dc.date.available | 2020-10-05T05:45:55Z | |
dc.date.issued | 2020-09-01 | en_US |
dc.description.abstract | Nicholas White and coauthors discuss chloroquine and hydroxychloroquine pharmacology in the context of possible treatment of SARS-CoV-2 infection. | en_US |
dc.identifier.citation | PLoS medicine. Vol.17, No.9 (2020), e1003252 | en_US |
dc.identifier.doi | 10.1371/journal.pmed.1003252 | en_US |
dc.identifier.issn | 15491676 | en_US |
dc.identifier.other | 2-s2.0-85089626135 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/59183 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089626135&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089626135&origin=inward | en_US |